BALDUINI, WALTER
 Distribuzione geografica
Continente #
NA - Nord America 16.381
EU - Europa 12.428
AS - Asia 5.322
SA - Sud America 550
Continente sconosciuto - Info sul continente non disponibili 303
AF - Africa 100
OC - Oceania 45
Totale 35.129
Nazione #
US - Stati Uniti d'America 16.108
NL - Olanda 3.843
CN - Cina 2.608
GB - Regno Unito 2.446
SG - Singapore 1.409
IT - Italia 1.365
UA - Ucraina 1.095
DE - Germania 776
RU - Federazione Russa 690
SE - Svezia 651
FI - Finlandia 647
TR - Turchia 475
BR - Brasile 402
FR - Francia 288
VN - Vietnam 227
IE - Irlanda 206
CA - Canada 162
BD - Bangladesh 118
IN - India 105
HK - Hong Kong 82
PL - Polonia 79
BE - Belgio 73
ES - Italia 66
JP - Giappone 62
AT - Austria 52
MX - Messico 49
AR - Argentina 47
AU - Australia 38
EC - Ecuador 32
CO - Colombia 30
ZA - Sudafrica 26
KE - Kenya 24
KR - Corea 24
RO - Romania 20
ID - Indonesia 18
IQ - Iraq 18
LT - Lituania 18
PK - Pakistan 18
AE - Emirati Arabi Uniti 16
IR - Iran 14
MY - Malesia 14
CH - Svizzera 13
JM - Giamaica 13
MA - Marocco 13
SA - Arabia Saudita 13
EG - Egitto 12
EU - Europa 12
IL - Israele 12
HR - Croazia 11
VE - Venezuela 11
CR - Costa Rica 10
SI - Slovenia 10
SM - San Marino 10
TH - Thailandia 10
AL - Albania 9
JO - Giordania 9
PH - Filippine 9
KZ - Kazakistan 8
PE - Perù 8
TW - Taiwan 8
AZ - Azerbaigian 7
CL - Cile 7
EE - Estonia 7
HU - Ungheria 7
UZ - Uzbekistan 7
DK - Danimarca 6
HN - Honduras 6
BB - Barbados 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
PT - Portogallo 5
TG - Togo 5
TN - Tunisia 5
AM - Armenia 4
BO - Bolivia 4
DZ - Algeria 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
UY - Uruguay 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BM - Bermuda 2
BZ - Belize 2
CG - Congo 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GR - Grecia 2
Totale 34.804
Città #
Amsterdam 3.820
Dallas 2.516
Southend 2.106
Ashburn 1.423
Woodbridge 1.393
Fairfield 1.153
Houston 957
Jacksonville 871
San Jose 754
Singapore 714
Ann Arbor 666
Chandler 578
Cambridge 498
Seattle 491
Nanjing 467
Wilmington 434
Helsinki 361
Beijing 350
Munich 350
Izmir 331
Boardman 274
Council Bluffs 268
Urbino 247
New York 230
Dublin 197
Nanchang 191
Los Angeles 161
Lauterbourg 142
Princeton 132
San Mateo 114
Santa Clara 110
Hangzhou 106
Austin 98
Tianjin 94
Shenyang 92
Changsha 91
Ho Chi Minh City 89
Moscow 82
Buffalo 76
Toronto 75
Hebei 74
Bremen 72
Hong Kong 72
Jiaxing 70
Brussels 69
Kunming 62
London 62
São Paulo 62
Velikiy Novgorod 61
Rome 60
Istanbul 58
San Diego 58
San Francisco 56
Dearborn 55
Düsseldorf 53
Milan 53
Hanoi 51
Jinan 51
The Dalles 51
Guangzhou 49
Mülheim 48
Shanghai 48
Frankfurt am Main 45
Orem 44
Chicago 42
Phoenix 42
Atlanta 39
Des Moines 39
Kraków 39
Round Rock 39
Montreal 36
Vienna 35
Brooklyn 33
Denver 33
Nuremberg 28
Taizhou 28
Tokyo 28
Warsaw 28
Lanzhou 27
Chennai 24
Kocaeli 24
Ningbo 23
Turku 23
Mexico City 22
Zhengzhou 22
Bologna 21
Venice 21
Rio de Janeiro 20
Stockholm 20
Fermo 19
Johannesburg 19
Bengaluru 18
Nairobi 18
Ancona 17
Seongnam 17
Wuppertal 17
Changchun 16
Haikou 16
Pesaro 16
West Jordan 16
Totale 25.411
Nome #
1,3 dideazaadenosine is a mitogen for cultured mammalian cells. 3.250
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.209
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 607
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 442
Rapid modulation of the silent information regulator 1 by melatonin after hypoxia-ischemia in the neonatal rat brain 406
Mitochondrial ascorbic acid prevents mitochondrial O2.- formation, an event critical for U937 cell apoptosis induced by arsenite through both autophagic-dependent and independent mechanisms 395
Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat 327
Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates 321
Melatonin and Mitochondrial Function: Insights into Bioenergetics, Dynamics, and Gene Regulation 313
Antioxidant and Analgesic Effect of Melatonin Involving Sirtuin 1: A Randomised Pilot Clinical Study 311
Experimental models of hypoxic-ischemic encephalopathy: hypoxia-ischemia in the immature rat 304
Microencephalic rats as a model for cognitive disorders. 291
Caspase-3 and calpain activities after acute and repeated ethanol administration during the rat brain growth spurt 285
Autophagy in hypoxia-ischemia induced brain injury 283
Autophagy researchers 275
The study of the mechanism of arsenite toxicity in respiration-deficient cells reveals that NADPH oxidase-derived superoxide promotes the same downstream events mediated by mitochondrial superoxide in respiration-proficient cells 274
New therapeutic strategies in perinatal stroke 272
Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia 267
CHRONIC CAFFEINE TREATMENT AND ADENOSINE RECEPTORS 266
AUTORADIOGRAPHIC LOCALIZATION OF [3H]THIOCOLCHICOSIDE BINDING SITES IN THE RAT BRAIN AND SPINAL CORD 262
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination After Hypoxia-Ischemia in Neonatal Rats 261
LONG-LASTING TOLERANCE TO STIMULATORY EFFECTS BY PERINATAL CAFFEINE TREATMENT 257
Melatonin reduces endoplasmic reticulum stress and preserves sirtuin 1 expression in neuronal cells of newborn rats after hypoxia-ischemia 257
Analgesic effect of melatonin in children undergoing surgery: a pilot randomized, placebo-controlled study 256
MICROENCEPHALIC RATS AS A MODEL FOR COGNITIVE DISORDERS 255
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 250
Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat 248
NOCTURNAL HYPERACTIVITY INDUCED BY PRENATAL METHYLAZOXYMETHANOL ADMINISTRATION AS MEASURED IN A COMPUTERIZED RESIDENTIAL MAZE 244
Involvement of miRNAs in Placental Alterations Mediated by Oxidative Stress 239
Mitochondria as cellular hub in neonatal hypoxic-ischemic encephalopathy: identification of melatonin-responsive biomarkers predicting brain damage severity 234
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4 234
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 231
Meccanismi di tossicità 228
2-(SUBSTITUTED)AMINO-2,8-DIAZASPIRO[4,5]DECAN-1,3-DIONES AS POTENTIAL MUSCARINIC AGONISTS: SYNTHESIS, MODELING AND BINDING STUDIES 227
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 227
ADENOSINE AND 2-CHLOROADENOSINE DEAZA-ANALOGUES AS ADENOSINE RECEPTOR AGONISTS 226
Increased autophagy reduces endoplasmic reticulum stress after neonatal hypoxia–ischemia: Role of protein synthesis and autophagic pathways 226
The use of melatonin in hypoxic-ischemic brain damage: an experimental study 223
Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke 222
Free iron, total F(2)-isoprostanes and total F(4)-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin 221
Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia 221
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage 218
EFFECT OF PRENATAL TREATMENT WITH METHYLAZOXYMETHANOL ON CARBACHOL-, NOREPINEPHRINE- AND GLUTAMATE-STIMULATED PHOSPHOINOSITIDE METABOLISM IN THE NEONATAL, YOUNG AND ADULT OFFSPRING 218
TREATMENT WITH METHYLAZOXYMETHANOL AT DIFFERENT GESTATIONAL DAYS: PHYSICAL, REFLEX DEVELOPMENT AND SPONTANEOUS ACTIVITY IN THE OFFSPRING 217
Autophagy in hypoxia-ischemia induced brain injury: Evidence and speculations 216
Modulation of muscarinic receptor-stimulated phosphoinositide breakdown by sulfhydryl group modification is a general response in different rat brain regions and depends on the stage of brain development. 214
Pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation 214
Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation 213
Melatonin modulates neonatal brain inflammation through endoplasmic reticulum stress, autophagy, and miR-34a/silent information regulator 1 pathway 212
BEHAVIORAL AND BIOCHEMICAL EFFECTS OF EARLY POSTNATAL PARATHION EXPOSURE IN THE RAT 209
Inhibition of rapamycin-induced autophagy causes necrotic cell death associated with Bax/Bad mitochondrial translocation 207
Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury 207
CHRONIC CHLORDIAZEPOXIDE TREATMENT ON ADULT AND NEWBORN RATS: EFFECTS ON GABA-BENZODIAZEPINE SYSTEM 204
SIMVASTATIN PROTECTS AGAINST THE LONG-LASTING BEHAVIORAL AND MORPHOLOGICAL CONSEQUENCES OF A NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURY 204
Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats 204
Melatonin reshapes the mitochondrial network and promotes intercellular mitochondrial transfer via tunneling nanotubes after ischemic-like injury in hippocampal HT22 cells 204
Automated—Mechanical Procedure Compared to Gentle Enzymatic Tissue Dissociation in Cell Function Studies 204
REGIONAL DEVELOPMENT OF CARBACHOL-, GLUTAMATE-, NOREPINEPHRINE-, AND SEROTONIN-STIMULATED PHOSPHOINOSITIDE METABOLISM IN RAT BRAIN 202
CHOLINERGIC HYPERINNERVATION IN THE CEREBRAL CORTEX OF MICOENCEPHALIC RATS DOES NOT RESULT IN MUSCARINIC RECEPTOR DOWN-REGULATION OR IN ALTERATION OF RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM 202
TOSSICOLOGIA: I fondamenti dell'azione delle sostanze tossiche - V Edizione 201
Preclinical randomized controlled multicenter trials (pRCT) in stroke research: a new and valid approach to improve translation? 199
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 2-(4-CHLORO-3-HYDROXYPHENYL)ETHYLAMINE AND N,N-DIALKYL DERIVATIVES AS DOPAMINE RECEPTOR LIGANDS 198
3-Demetoxy-3-glycosylaminothiocolchicines: synthesis of a new class of putative muscle relaxant compounds. 197
ADENOSINE MODULATION OF HISTAMINE-STIMULATED PHOSPHOINOSITIDE METABOLISM IN RAT CORTICAL SLICES 196
“Experimental Models of Hypoxic-Ischemic Encephalopathy: Hypoxia-Ischemia in the Immature Rat” 195
SYNTHESIS AND DOPAMINE RECEPTOR AFFINITIES OF 2-(4-FLUORO-3 HYDROXYPHENYL) ETHYLAMINE AND N-SUBSTITUTED DERIVATIVES 193
Chronic caffeine treatment: its relevance for studying the functional role of adenosine receptors 193
SELECTIVE ALTERATION IN B-50 (GAP-43) PHOSPHORYLATION IN BRAIN AREAS OF ANIMALS CHARACTERIZED BY COGNITIVE IMPAIRMENT 192
Neuroprotective Effect of Simvastatin in Stroke: A Comparison Between Adult and Neonatal Rat Models of Cerebral Ischemia 192
ADMINISTRATION OF ETHANOL DURING THE RAT'S BRAIN GROWTH SPURT CAUSES DOSE - DEPENDENT MICROENCEPHALY AND INHIBITION OF MUSCARINIC RECEPTOR - STIMULATED PHOSPHOINOSITIDE METABOLISM 190
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 190
Nurturing a young field 190
Cyclodextrine given intravenously after severe neonatal hypoxia, alone or in combination with progesterone, increased autophagy activation and reduced endoplasmatic reticulum stress in prefrontal cortex 188
Expression of hexokinase mRNA in human hippocampus 185
Inhibition of nucleic acids and protein synthesis by deazaadenosine derivatives: a study on structure-activity relationships 185
Effetti tossici su sistema endocrino, immunitario e cute 185
ACTIVITY OF N-(2-PHENYLETHYL)-N-N-PROPYL-2-(3-HYDROXYPHENYL) ETHYLAMINE DERIVATIVES AS DOPAMINE RECEPTOR LIGANDS 184
Characterization of [3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex 183
Perinatal Brain Injury: Mechanisms and Potential Pharmacological Therapies: The role of SIRT1 in the neuroprotective effect of melatonin and of endothelin-1 in oligodendrocyte progenitor cell development 180
EARLY POSTNATAL CHLORDIAZEPOXIDE ADMINISTRATION: PERMANENT BEHAVIORAL EFFECTS IN THE MATURE RAT AND POSSIBLE INVOLVEMENT OF THE GABA-BENZODIAZEPINE RECEPTOR SYSTEM 179
BEHAVIORAL AND BIOCHEMICAL EFFECTS OF POSTNATAL PARATHION EXPOSURE IN THE RAT 178
Tossicocinetica e tossicogenetica 177
POTASSIUM IONS POTENTIATE THE MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM IN CEREBRAL CORTEX SLICES: A COMPARISON OF NEONATAL AND ADULT RATS 173
TREATMENT WITH METHYLAZOXYMETHANOL AT DIFFERENT GESTATIONAL DAYS: TWO-WAY SHUTTLE BOX AVOIDANCE AND RESIDENTIAL MAZE ACTIVITY IN RAT OFFSPRING 173
Tossicologia generale e applicata ai farmaci 173
DEVELOPMENTAL NEUROTOXICITY OF ETHANOL: IN VITRO INHIBITION OF MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM IN BRAIN FROM NEONATAL BUT NOT ADULT RATS 172
New pharmacological approaches in infants with hypoxic-ischemic encephalopathy 172
INTERACTION OF ETHANOL AND ANOXIA WITH MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE METABOLISM DURING BRAIN DEVELOPMENT 170
DISPLACEMENT OF |3H|-N6-CYCLOEXYLADENOSINE BINDING TO RAT CORTICAL MEMBRANES BY AN HYDROALCOHOLIC EXTRACT OF VALERIANA OFFICINALIS 168
Novel 3-O-glycosyl-3-demethylthiocolchicines as ligands for glycine and gamma-aminobutyric acid receptors. 168
Tossicologia cardiaca e polmonare 167
The muscarinic receptor-stimulated phosphoinositide metabolism as a potential target for the neurotoxicity of ethanol during brain development 166
Long-lasting behavioral alterations following an hypoxic/ischemic brain injury in neonatal rats 162
INTERACTION OF SOME 2-HYDROXYBENZYLPIPERIDINES WITH DOPAMINE RECEPTORS 161
DEVELOPMENTAL NEUROTOXICITY OF ETHANOL: FURTHER EVIDENCE FOR AN INVOLVEMENT OF MUSCARINIC RECEPTOR-STIMULATED PHOSPHOINOSITIDE HYDROLYSIS 160
Guidelines for the use and interpretation of assays for monitoring autophagy (review) 159
Assessing Autophagy in Archived Tissue or How to Capture Autophagic Flux from a Tissue Snapshot 159
Melatonin Reduces Mito-Inflammation in Ischaemic Hippocampal HT22 Cells and Modulates the cGAS–STING Cytosolic DNA Sensing Pathway and FGF21 Release 157
Human-rat integrated microRNAs profiling identified a new neonatal cerebral hypoxic-ischemic pathway melatonin-sensitive 156
Moderate ethanol consumption and cigarette smoking habit fail to affect acutely ethanol induced hypertrigliceridimia in humans 155
Totale 28.437
Categoria #
all - tutte 111.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.104 0 0 0 230 22 20 67 110 108 85 39 423
2022/20232.106 265 132 61 211 184 443 23 155 317 83 136 96
2023/2024677 70 54 49 71 45 146 49 45 10 61 27 50
2024/20253.011 145 145 483 146 94 314 470 220 328 184 285 197
2025/202612.113 543 963 2.393 940 622 411 798 197 4.147 506 369 224
2026/20271.932 314 320 791 507 0 0 0 0 0 0 0 0
Totale 35.129